The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Bioequivalence and the immunogenicity of biopharmaceuticals
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Casadevall, N., Nataf, J., Viron, B., Kolta, A., Kiladjian, J.-J., Martin-Dupont, P., Michaud, P., Papo, T., Ugo, V., Teyssandier, I., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011931 · Cited by 1,246
Olsen, E., Duvic, M., Frankel, A., Kim, Y., Martin, A., Vonderheid, E., Jegasothy, B., Wood, G., Gordon, M., Heald, P., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.376 · Cited by 609
Cleland, J. L., Powell, M., & Shire, S. J. (1993) · PubMed · Cited by 543
Immunogenicity and Allergenic Potential of Animal and Human Insulins
Schernthaner, G. (1993) · Diabetes Care · doi:10.2337/diacare.16.3.155 · Cited by 247
Ross, C., Clemmesen, K. M., Svenson, M., S�rensen, P. S., Koch‐Henriksen, N., Skovgaard, G. L., Bendtzen, K., & the Danish Multiple Sclerosis Study Group (2000) · Annals of Neurology · doi:10.1002/1531-8249(200011)48:5<706::aid-ana3>3.0.co;2-v · Cited by 240
Role of Aggregated Human Growth Hormone (hGH) in Development of Antibodies to hGH*
MOORE, W. V., & LEPPERT, P. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-51-4-691 · Cited by 220
Development of antibodies to unprotected glycosylation sites on recombinant human GM-CSF
Gribben, J. G., Devereux, S., Thomas, N. S. B., Keim, M., Jones, H. M., Goldstone, A. H., & Linch, D. C. (1990) · The Lancet · doi:10.1016/0140-6736(90)90665-r · Cited by 210
Rosendaal, F., Nieuwenhuis, H., van den Berg, H., Heijboer, H., Mauser- Bunschoten, E., van der Meer, J., Smit, C., Strengers, P., & Briet, E. (1993) · Blood · doi:10.1182/blood.v81.8.2180.2180 · Cited by 194
Prescott, R., Nakai, H., Saenko, E. L., Scharrer, I., Nilsson, I. M., Humphries, J. E., Hurst, D., Bray, G., Scandella, D., & Groups, T. R. A. K. S. (1997) · Blood · doi:10.1182/blood.v89.10.3663 · Cited by 183
Construction and Characterization of a Lipotes vexillifer Genomic DNA BAC Library
Du, B. X., Zhang, X., Fang, S., & Wang, D. (2007) · ZOOLOGICAL SCIENCE · doi:10.2108/zsj.24.401 · Cited by 125
Cited by
Protein Therapeutics: A Summary and Pharmacological Classification
Leader, B., Baca, Q. J., & Golan, D. E. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2399 · Cited by 2,161
Filipe, V., Hawe, A., & Jiskoot, W. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0073-2 · Cited by 1,885
Structure-Immunogenicity Relationships of Therapeutic Proteins
Hermeling, S., Crommelin, D. J. A., Schellekens, H., & Jiskoot, W. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000029275.41323.a6 · Cited by 617
Self-citationChen, B.-M., Cheng, T.-L., & Roffler, S. R. (2021) · ACS Nano · doi:10.1021/acsnano.1c05922 · Cited by 563
Immunogenicity of therapeutic proteins: Clinical implications and future prospects
Schellekens, H. (2002) · Clinical Therapeutics · doi:10.1016/s0149-2918(02)80075-3 · Cited by 556
Self-citationAnalytical tools for characterizing biopharmaceuticals and the implications for biosimilars
Berkowitz, S. A., Engen, J. R., Mazzeo, J. R., & Jones, G. B. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3746 · Cited by 529
Characterizing biological products and assessing comparability following manufacturing changes
Chirino, A. J., & Mire-Sluis, A. (2004) · Nature Biotechnology · doi:10.1038/nbt1030 · Cited by 364
Shankar, G., Arkin, S., Cocea, L., Devanarayan, V., Kirshner, S., Kromminga, A., Quarmby, V., Richards, S., Schneider, C. K., Subramanyam, M., et al. (2014) · The AAPS Journal · doi:10.1208/s12248-014-9599-2 · Cited by 353
Immunogenicity to Therapeutic Proteins: Impact on PK/PD and Efficacy
Chirmule, N., Jawa, V., & Meibohm, B. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9340-y · Cited by 335
Induction and analysis of aggregates in a liquid IgG1-antibody formulation
Mahler, H.-C., Müller, R., Frieβ, W., Delille, A., & Matheus, S. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.12.004 · Cited by 309
Principles, approaches, and challenges for predicting protein aggregation rates and shelf life
Weiss, W. F., Young, T. M., & Roberts, C. J. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21521 · Cited by 308
Mellstedt, H., Niederwieser, D., & Ludwig, H. (2008) · Annals of Oncology · doi:10.1093/annonc/mdm345 · Cited by 271
Joubert, M. K., Hokom, M., Eakin, C., Zhou, L., Deshpande, M., Baker, M. P., Goletz, T. J., Kerwin, B. A., Chirmule, N., Narhi, L. O., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.330902 · Cited by 268
An, M., Raguram, A., Du, S. W., Banskota, S., Davis, J. R., Newby, G. A., Chen, P. Z., Palczewski, K., & Liu, D. R. (2024) · Nature Biotechnology · doi:10.1038/s41587-023-02078-y · Cited by 263
Shankar, G., Pendley, C., & Stein, K. E. (2007) · Nature Biotechnology · doi:10.1038/nbt1303 · Cited by 260
In vitro models for immunogenicity prediction of therapeutic proteins
Groell, F., Jordan, O., & Borchard, G. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.06.008 · Cited by 53
Uchino, T., Miyazaki, Y., Yamazaki, T., & Kagawa, Y. (2017) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12765 · Cited by 49
Bueno, J., Long, D., Kauffman, J. F., & Arzhantsev, S. (2015) · Analytical Chemistry · doi:10.1021/acs.analchem.5b01606 · Cited by 14
Metadata
- Authors
- Schellekens, H.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2002-06
- Volume
- 1
- Issue
- 6
- Pages
- 457-462
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1979325667
- Cited by
- 534
- References
- 36
- FWCI
- 0.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.